Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation

Abstract Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: B. Hernández-Ochoa, G. Navarrete-Vázquez, C. Nava-Zuazo, A. Castillo-Villanueva, S. T. Méndez, A. Torres-Arroyo, S. Gómez-Manzo, J. Marcial-Quino, M. Ponce-Macotela, Y. Rufino-González, M. Martínez-Gordillo, G. Palencia-Hernández, N. Esturau-Escofet, E. Calderon-Jaimes, J. Oria-Hernández, H. Reyes-Vivas
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a2e2eb22efc4463c908cf0ac908341c3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a2e2eb22efc4463c908cf0ac908341c3
record_format dspace
spelling oai:doaj.org-article:a2e2eb22efc4463c908cf0ac908341c32021-12-02T12:32:31ZNovel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation10.1038/s41598-017-07612-y2045-2322https://doaj.org/article/a2e2eb22efc4463c908cf0ac908341c32017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07612-yhttps://doaj.org/toc/2045-2322Abstract Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drugs. Recently, it has determined that gastric proton-pump inhibitors (PPI) have anti-giardiasic activity. The glycolytic enzyme, triosephosphate isomerase (GlTIM), is one of its potential targets. Therefore, we employed the scaffold of PPI to design new compounds aimed to increase their antigiardial capacity by inactivating GlTIM. Here we demonstrated that two novel PPI-derivatives (BHO2 and BHO3), have better anti-giardiasic activity than omeprazole in concentrations around 120–130 µM, without cytotoxic effect on mammal cell cultures. The derivatives inactivated GlTIM through the chemical modification of Cys222 promoting local structural changes in the enzyme. Furthermore, derivatives forms adducts linked to Cys residues through a C-S bond. We demonstrated that PPI can be used as scaffolds to design better antiparasitic molecules; we also are proposing a molecular mechanism of reaction for these novel derivatives.B. Hernández-OchoaG. Navarrete-VázquezC. Nava-ZuazoA. Castillo-VillanuevaS. T. MéndezA. Torres-ArroyoS. Gómez-ManzoJ. Marcial-QuinoM. Ponce-MacotelaY. Rufino-GonzálezM. Martínez-GordilloG. Palencia-HernándezN. Esturau-EscofetE. Calderon-JaimesJ. Oria-HernándezH. Reyes-VivasNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
B. Hernández-Ochoa
G. Navarrete-Vázquez
C. Nava-Zuazo
A. Castillo-Villanueva
S. T. Méndez
A. Torres-Arroyo
S. Gómez-Manzo
J. Marcial-Quino
M. Ponce-Macotela
Y. Rufino-González
M. Martínez-Gordillo
G. Palencia-Hernández
N. Esturau-Escofet
E. Calderon-Jaimes
J. Oria-Hernández
H. Reyes-Vivas
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
description Abstract Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drugs. Recently, it has determined that gastric proton-pump inhibitors (PPI) have anti-giardiasic activity. The glycolytic enzyme, triosephosphate isomerase (GlTIM), is one of its potential targets. Therefore, we employed the scaffold of PPI to design new compounds aimed to increase their antigiardial capacity by inactivating GlTIM. Here we demonstrated that two novel PPI-derivatives (BHO2 and BHO3), have better anti-giardiasic activity than omeprazole in concentrations around 120–130 µM, without cytotoxic effect on mammal cell cultures. The derivatives inactivated GlTIM through the chemical modification of Cys222 promoting local structural changes in the enzyme. Furthermore, derivatives forms adducts linked to Cys residues through a C-S bond. We demonstrated that PPI can be used as scaffolds to design better antiparasitic molecules; we also are proposing a molecular mechanism of reaction for these novel derivatives.
format article
author B. Hernández-Ochoa
G. Navarrete-Vázquez
C. Nava-Zuazo
A. Castillo-Villanueva
S. T. Méndez
A. Torres-Arroyo
S. Gómez-Manzo
J. Marcial-Quino
M. Ponce-Macotela
Y. Rufino-González
M. Martínez-Gordillo
G. Palencia-Hernández
N. Esturau-Escofet
E. Calderon-Jaimes
J. Oria-Hernández
H. Reyes-Vivas
author_facet B. Hernández-Ochoa
G. Navarrete-Vázquez
C. Nava-Zuazo
A. Castillo-Villanueva
S. T. Méndez
A. Torres-Arroyo
S. Gómez-Manzo
J. Marcial-Quino
M. Ponce-Macotela
Y. Rufino-González
M. Martínez-Gordillo
G. Palencia-Hernández
N. Esturau-Escofet
E. Calderon-Jaimes
J. Oria-Hernández
H. Reyes-Vivas
author_sort B. Hernández-Ochoa
title Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
title_short Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
title_full Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
title_fullStr Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
title_full_unstemmed Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
title_sort novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a2e2eb22efc4463c908cf0ac908341c3
work_keys_str_mv AT bhernandezochoa novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT gnavarretevazquez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT cnavazuazo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT acastillovillanueva novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT stmendez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT atorresarroyo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT sgomezmanzo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT jmarcialquino novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT mponcemacotela novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT yrufinogonzalez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT mmartinezgordillo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT gpalenciahernandez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT nesturauescofet novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT ecalderonjaimes novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT joriahernandez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
AT hreyesvivas novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation
_version_ 1718394052195385344